Lupin

New launches to make Antara brand in US for Lupin

New launches to make Antara brand in US for LupinDrug-producer Lupin is situated to showcase two extra qualities of its cholesterol-bringing down medication Antara (fenofibrate) in the US.

The new launches are part of the organization's methodology to help assemble the mark, said Managing Director Nilesh Gupta, especially since there as of recently is a blandly comparable form in the business.

Lupin Receives Approval for Oral Contraceptive Daysee Tablets in US Market

LupinLupin has received a final nod from US FDA for sale of Daysee pill in the U. S. market. The approval was given to Lupin's subsidiary Lupin Pharmaceuticals Inc for a contraceptive pill. Lupin has already begun shipping Daysee pills, which is a generic version of Seasonique tablets of Teva Pharmaceuticals.

Lupin Gets Approval for Suprax Oral Suspension

LupinLupin Ltd. has revaled in a statement that it has got the approval for Suprax oral suspension in the strength of 500mg/5mL from the United States Food and Drugs Administration. The approval was received by the Lupin's subsidiary Lupin Pharmaceuticals, Inc, said Lupin.

Lupin Launches Generic Version of Abott’s TriCor

Lupin Launches Generic Version of Abott’s TriCorIndia's drug maker company has come up with generic version of anti-cholesterol drug Tricor that is marketed by Abott.

Lupin Pharmaceuticals Gets Approval for Generic Medicine

LupinLupin Pharmaceuticals, a subsidiary of Lupin, has got green signal from the US Food and Drugs Administration (FDA) to produce generic version of its tablets known as Irbesartan tablets.

The tablets are generic version of Avapro tablets being manufactured by Sanofi Aventis, which now have received permission from the regulators FDA. The tablet is meant for diabetic patients, who take the same for hypertension as well as for nephropathy.

Good News for Lupin

Good News for LupinLupin Limited's US subsidiary, Lupin Pharmaceuticals, Inc has been able to receive the final authorization for the company's Abbreviated New Drug Application for its lamotrigine tablets, 25 mg, 100 mg, 150 mg and 200 mg strengths, from the US Food and Drug Administration.

Advertisements